Display options
Share it on

Int J Ophthalmol. 2017 Apr 18;10(4):550-554. doi: 10.18240/ijo.2017.04.08. eCollection 2017.

Expression and role of specificity protein 1 in the sclera remodeling of experimental myopia in guinea pigs.

International journal of ophthalmology

Bo Jiang, Zhang-You Wu, Zi-Cheng Zhu, Gen-Jie Ke, Yue-Chun Wen, Si-Qin Sun

Affiliations

  1. Department of Ophthalmology, Anhui Provincial Hospital, Anhui Medical University, Hefei 230001, Anhui Province, China.

PMID: 28503426 PMCID: PMC5406631 DOI: 10.18240/ijo.2017.04.08

Abstract

AIM: To study the expression of collagen I and transcription factor specificity protein 1 (Sp1), a transforming growth factor-β1 (TGF-β1) downstream target, and reveal the impact of the TGF-β1-Sp1 signaling pathway on collagen remodeling in myopic sclera.

METHODS: Seventy-five 1-week-old guinea pigs were randomly divided into normal control, form deprivation myopia (FDM), and self-control groups. FDM was induced for different times using coverage with translucent latex balloons and FDM recovery was performed for 1wk after 4wk treatment; then, changes in refractive power and axial length were measured. Immunohistochemistry and reverse transcription-polymerase chain reaction were used to evaluate dynamic changes in collagen I and Sp1 expression in the sclera of guinea pigs with emmetropia and experimental myopia, and the relationship between collagen I and Sp1 levels was analyzed.

RESULTS: In the FDM group, the refractive power was gradually changed (from 2.09±0.30 D at week 0 to -1.23±0.69 D, -4.17±0.59 D, -7.07±0.56 D, and -4.30±0.58 D at weeks 2, 4, 6, and 1wk after 4wk, respectively;

CONCLUSION: Our data indicate that transcription factor Sp1 may be involved in the regulation of type I collagen synthesis/degradation during myopic sclera remodeling, suggesting that TGF-β1 signaling plays a role in the development and progression of myopia.

Keywords: collagen I; form-deprivation myopia; sclera remodeling; specificity protein 1; transforming growth factor-β1

References

  1. Front Oncol. 2016 Mar 21;6:61 - PubMed
  2. J Ophthalmol. 2016;2016:5126560 - PubMed
  3. J Biol Chem. 2004 Apr 30;279(18):18121-6 - PubMed
  4. Int J Clin Exp Med. 2015 Nov 15;8(11):20355-67 - PubMed
  5. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2009 Apr;34(4):349-55 - PubMed
  6. Int J Ophthalmol. 2015 Feb 18;8(1):39-45 - PubMed
  7. JAMA. 2015 Sep 15;314(11):1142-8 - PubMed
  8. Eye (Lond). 2016 Jun;30(6):796-804 - PubMed
  9. Exp Eye Res. 2009 Mar;88(3):458-66 - PubMed
  10. Exp Eye Res. 2009 Jun 15;89(1):101-8 - PubMed
  11. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2005 Nov;21(6):679-82 - PubMed
  12. PLoS One. 2015 Jan 13;10(1):e0115524 - PubMed
  13. Mol Vis. 2014 Jul 02;20:977-87 - PubMed
  14. J Huazhong Univ Sci Technolog Med Sci. 2007 Oct;27(5):601-4 - PubMed
  15. J Biol Chem. 2003 May 9;278(19):16587-94 - PubMed
  16. FEBS J. 2015 Jan;282(2):224-58 - PubMed

Publication Types